167 related articles for article (PubMed ID: 17851872)
1. Loss of histidine decarboxylase as a marker of malignant transformation and dedifferentiation of B-cells infiltrating the skin. A case report of a therapy-resistant multiple myeloma complicated by skin infiltration.
Varkonyi J; Karádi I; Szocs K; Sugár I; Sápi Z; Marschalko M; Pállinger E; Darvas Z; Falus A
Acta Oncol; 2008; 47(3):458-61. PubMed ID: 17851872
[No Abstract] [Full Text] [Related]
2. [Plasmacytic skin infiltration in multiple myeloma].
Molnár K; Karádi I; Sugár I; Sápi Z; Marschalkó M; Pálinger E; Darvas Z; Pócza P; Falus A; Vereczkei A; Várkonyi J
Orv Hetil; 2008 May; 149(19):877-81. PubMed ID: 18450547
[TBL] [Abstract][Full Text] [Related]
3. Signet-ring plasma cell myeloma.
Grier DD; Robbins K
Am J Hematol; 2012 Jun; 87(6):625. PubMed ID: 21953819
[No Abstract] [Full Text] [Related]
4. [Multiple myeloma with cutaneous involvement in a patient with long-standing MGUS].
Giraldo MP; Delgado MP; Rubio Félix D
Sangre (Barc); 1993 Apr; 38(2):156-7. PubMed ID: 8516731
[No Abstract] [Full Text] [Related]
5. [Initial central nervous system involvement in a case of non-secretory multiple myeloma].
Calavia J; Loyola I; Richard C; Baro J; Recio M; Cuadrado MA; Zubizarreta A
Sangre (Barc); 1993 Oct; 38(5):389-91. PubMed ID: 8140502
[TBL] [Abstract][Full Text] [Related]
6. CD138 shedding in plasma cell myeloma.
Grigoriadis G; Whitehead S
Br J Haematol; 2010 Aug; 150(3):249. PubMed ID: 20433680
[No Abstract] [Full Text] [Related]
7. Neoplasms of terminally differentiated B lymphocytes.
Holbert JM
Clin Lab Med; 1988 Mar; 8(1):197-210. PubMed ID: 3282759
[TBL] [Abstract][Full Text] [Related]
8. Hepatic and renal plasma cell lesions in a patient with multiple myeloma in hematological remission.
Galani Z; Viniou N; Kyrtsonis MC; Sachanas S; Antoniou T; Dimopoulou MN; Vassilakopoulos TP; Korkolopoulou P; Nakopoulou L; Patsouris E; Pangalis GA
Anticancer Res; 2007; 27(1B):571-4. PubMed ID: 17348443
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow plasma cell infiltration in multiple myeloma.
de Gramont A; Benitez O; Smadja N; Brissaud P; Sirinelli A; Hubert D; Krulik M; Debray J
Br J Haematol; 1984 Jun; 57(2):351-3. PubMed ID: 6733051
[No Abstract] [Full Text] [Related]
10. Temporal bone involvement in multiple myeloma.
Naraev BG; Linthicum FH
Otol Neurotol; 2006 Jun; 27(4):580-1. PubMed ID: 16691154
[No Abstract] [Full Text] [Related]
11. Bence Jones myeloma with signet-ring-like plasma cells.
Caenazzo A; Sartori D; Poletti A
Haematologica; 1997; 82(1):122. PubMed ID: 9107097
[No Abstract] [Full Text] [Related]
12. Unusual evolution of Waldenström's macroglobulinemia into osteolytic myeloma.
Jondeau K; Alterescu R; Franc B; Davi F; Massé JM; Boukour S; Le Parc JM; Cramer EM
Eur J Haematol; 2006 Jul; 77(1):74-9. PubMed ID: 16827885
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous nodules as a diagnostic clue in multiple myeloma.
Ballester-Martínez MA; González-García C; Fleta-Asín B; Burdaspal-Moratilla A; Santón-Roldán A; Jiménez-Gómez N; Martín-González MM; Olasolo PJ
Am J Dermatopathol; 2013 May; 35(3):377-80. PubMed ID: 23095339
[TBL] [Abstract][Full Text] [Related]
14. [First manifestation of multiple myeloma as lethal streptococcal sepsis].
Austein T; Kerstan H; Aue G; Schnieder I; von Bloh J; Badge S
Med Klin (Munich); 2006 Nov; 101(11):905-7. PubMed ID: 17235478
[TBL] [Abstract][Full Text] [Related]
15. Association of chronic lymphocytic leukaemia and multiple myeloma: report of a case and review of the literature.
Quaglino D; Paterlini P; De Pasquale A; Cretara G; Venturoni L
Haematologica; 1982 Aug; 67(4):576-88. PubMed ID: 6815016
[No Abstract] [Full Text] [Related]
16. Seemingly insignificant, but crucial morphological leads in the diagnosis of non-secretory multiple myeloma in an adolescent.
Mishra J; Chopra A; Gogia A; Kumar R
Indian J Pathol Microbiol; 2012; 55(1):130-2. PubMed ID: 22499328
[No Abstract] [Full Text] [Related]
17. Single-strand breaks or alkali-sensitive sites in the DNA of human myeloma plasma cells and chronic lymphocytic leukemia lymphocytes.
Brox L; Ng A; Pollock E; Khaliq A; Belch A
Can J Biochem Cell Biol; 1985 Sep; 63(9):977-81. PubMed ID: 3878222
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
19. The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.
Bataille R; Jégo G; Robillard N; Barillé-Nion S; Harousseau JL; Moreau P; Amiot M; Pellat-Deceunynck C
Haematologica; 2006 Sep; 91(9):1234-40. PubMed ID: 16956823
[TBL] [Abstract][Full Text] [Related]
20. "Dedifferentiated" adrenal cortical neoplasm.
Trezzi R; Poli F; Fellegara G
Int J Surg Pathol; 2009 Aug; 17(4):343-4. PubMed ID: 19443867
[No Abstract] [Full Text] [Related]
[Next] [New Search]
